2010
DOI: 10.1007/s00894-010-0679-7
|View full text |Cite
|
Sign up to set email alerts
|

Modeling the binding modes of stilbene analogs to cyclooxygenase-2: a molecular docking study

Abstract: Stilbene analogs are a new class of anti-inflammatory compounds that effectively inhibit COX-2, which is the major target in the treatment of inflammation and pain. In this study, docking simulations were conducted using AutoDock 4 software that focused on the binding of this class of compounds to COX-2 protein. Our aim was to better understand the structural and chemical features responsible for the recognition mechanism of these compounds, and to explore their binding modes of interaction at the active site … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
8
0
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(9 citation statements)
references
References 47 publications
0
8
0
1
Order By: Relevance
“…The most known stilbene, resveratrol (trans-3,5,4′-trihydroxystilbene), demonstrates anti-inflammatory activity, but it has also been shown to be a non-selective inhibitor of COX-1 and COX-2. [20,21] Murias et al [22] described a series of hydroxylated resveratrol analogues selective COX-2 inhibitors with potency comparable to or better than the clinically established celecoxib; furthermore, more recently, Bouaziz-Terrachet et al [23] showed that a series of stilbene analogs is able to selectively inhibit COX-2. Interestingly this is the first report which describes naturally occurring dihydrostilbenes able to selectively inhibit COX-2.…”
mentioning
confidence: 99%
“…The most known stilbene, resveratrol (trans-3,5,4′-trihydroxystilbene), demonstrates anti-inflammatory activity, but it has also been shown to be a non-selective inhibitor of COX-1 and COX-2. [20,21] Murias et al [22] described a series of hydroxylated resveratrol analogues selective COX-2 inhibitors with potency comparable to or better than the clinically established celecoxib; furthermore, more recently, Bouaziz-Terrachet et al [23] showed that a series of stilbene analogs is able to selectively inhibit COX-2. Interestingly this is the first report which describes naturally occurring dihydrostilbenes able to selectively inhibit COX-2.…”
mentioning
confidence: 99%
“…Such residues with higher binding energy contributions represented those contact points for electrostatic interactions, as described in molecular docking and Cα atom fluctuations. Similar information was described for the binding mode of stilbene analogs within the active site of COX-2 [35].…”
Section: Binding-free Energy Calculations Of the Best-docked 2-arylbementioning
confidence: 70%
“…Pocket S3 confined in the mouth of the active site and is delimited by Tyr355, Leu359, Val116 and Arg120. Shallow pocket S4 is localized in a hydrophobic area close to the hydrophobic pocket S2 which has a lesser number of residues, including Ile345, Leu534 and Leu531 . The inhibitors ( H 2 L and its complexes) were docked at the active site of COX‐2 and various interactions have been laid out (Figure ).…”
Section: Resultsmentioning
confidence: 86%